SCHEMBL4081113

SCHEMBL4081113

CCCCC(=O)Oc1cc(O)cc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
RECQL P46063 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
HTR7 P34969 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MIF P14174 1/20 0.38
CNR1 P21554 4/20 0.38
CNR2 P34972 4/20 0.38
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B3 P37058 1/20 0.37
PTGES O14684 1/20 0.36
TOP2A P11388 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992822 0.90 KMT2A (0.44) KMT2AKDM4EMEN1RECQLCYP4F2
SCHEMBL9752590 0.89 KMT2A (0.45) KMT2AKDM4EMEN1RECQLSMN1; SMN2
SCHEMBL27543984 0.85 CNR2 (0.39) HTR7SMN1; SMN2MIFCNR1CNR2
SCHEMBL15463445 0.83 KMT2A (0.48) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL29009919 0.83 KMT2A (0.42) KMT2AKDM4EMEN1RECQLCYP4F2
SCHEMBL9776801 0.83 PTGS2 (0.51) KMT2AKDM4EMEN1RECQLSMN1; SMN2
SCHEMBL4081074 0.83 KMT2A (0.45) KMT2AKDM4EMEN1RECQLSMN1; SMN2
SCHEMBL14060911 0.82 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL22471815 0.82 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL14831865 0.82 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638590-B2 Polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner CANON KABUSHIKI KAISHA (JP) 2009-12-29 US disclosed
US-7527809-B2 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof CANON KABUSHIKI KAISHA (JP) 2009-05-05 US disclosed
US-7452960-B2 Polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2008-11-18 US disclosed
US-7425432-B2 Polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor CANON KABUSHIKI KAISHA (JP) 2008-09-16 US disclosed
US-7393912-B2 Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2008-07-01 US disclosed
EP-1253475-B1 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KK (JP) 2007-08-08 EP disclosed
EP-1336635-B1 Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner CANON KK (JP) 2007-01-17 EP disclosed
US-7153622-B2 Polyhydroxyalkanate overcoating a coloring agent CANON KABUSHIKI KAISHA (JP) 2006-12-26 US disclosed
US-20060287473-A1 Novel polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner CANON KABUSHIKI KAISHA (JP) 2006-12-21 US disclosed
US-20060263432-A1 Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response CANON KABUSHIKI KAISHA (JP) 2006-11-23 US disclosed
EP-1336634-A2 Polyhydroxyalkanoate copolymer including unit having bromo group in side chain and method for producing the same CANON KABUSHIKI KAISHA (JP) 2003-08-20 EP disclosed
EP-1336635-A1 Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner CANON KABUSHIKI KAISHA (JP) 2003-08-20 EP disclosed
US-20030118931-A1 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KABUSHIKI KAISHA (JP) 2003-06-26 US disclosed
US-20030073804-A1 Polyhydroxyalkanoate, producing method therefor charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner CANON KABUSHIKI KAISHA (JP) 2003-04-17 US disclosed
US-20020164726-A1 Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same CANON KABUSHIKI KAISHA (JP) 2002-11-07 US disclosed
EP-1254918-A2 Novel polyhydroxyalkanoate, producing method therefor, charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner CANON KABUSHIKI KAISHA (JP) 2002-11-06 EP disclosed
EP-1253475-A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KABUSHIKI KAISHA (JP) 2002-10-30 EP disclosed
EP-1236754-A2 Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same CANON KABUSHIKI KAISHA (JP) 2002-09-04 EP disclosed
CN-1322768-A Polyhydroxy alkanoate and process for producing them with microbe CANON KK (JP) 2001-11-21 CN disclosed
CN-1321695-A Poly(hydroxy alkanoate), its preparation method and use of microbe in its preparation CANON KK (JP) 2001-11-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060263432-A1 Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response SKP1, HAMP, AUP1 KMT2A 3735/4885KDM4E 2061/4885MEN1 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.